Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma

Overview of attention for article published in Cancer Immunology, Immunotherapy, February 2008

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

patent: 5 patents

Citations

dimensions_citation: 203 Dimensions

Readers on

mendeley: 126 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 5 patents that reference this research output.

Expansion of non-haematopoietic tissue-resident gamma delta T cells and uses of these…

Grant US-11618885-B2

United States of America

γδ T cell expansion procedure

Grant US-11566222-B2

United States of America

METHODS FOR THE PRODUCTION OF TCR GAMMA DELTA+ T CELLS

Application EP-3623468-A1

European Patent Office

Gammadelta T cell expansion procedure

Grant US-10557117-B2

United States of America

METHODS FOR THE PRODUCTION OF TCR GAMMA DELTA+ T CELLS

Application WO-2016198480-A1

World Intellectual Property Organisation (WIPO)